Tonix Pharmaceuticals Holding Jobs & Careers

Berkeley Heights, NJ

About Tonix Pharmaceuticals Holding

Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD, and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.

Leadership at Tonix Pharmaceuticals Holding

The team at the top of the org chart.

Seth Lederman

CEO

47 reports

Jessica Edgar Morris

COO

22 reports

Gregory Sullivan

Chief Medical Officer

15 reports

Bradley Saenger

CFO

3 reports

Irina Ishak

General Counsel

3 reports

Board

R. Newcomb Stillwell

Director

David Grange

Director

James Treco

Director

Adeoye Olukotun

Director

Margaret Smith Bell

Director

Carolyn E. Taylor

Director

Open Jobs at Tonix Pharmaceuticals Holding (11)

Sort